Breaking news – Pagina 27 – AMD

Breaking news

Settembre 18, 2025 Alice Lione

FDA: Insulin pump correction: Tandem diabetes care issues correction for certain t:slim X2 insulin pumps due to risk for faulty speaker wiring that may cause malfunction and stop insulin delivery

15 settembre 2025 https://www.fda.gov/medical-devices/medical-device-recalls/insulin-pump-correction-tandem-diabetes-care-issues-correction-certain-tslim-x2-insulin-pumps-due?utm_medium=email&utm_source=govdelivery

Leggi

Settembre 15, 2025 Alice Lione

FDA: Development of non-opioid analgesics for chronic pain, draft guidance for industry; availability

11 settembre 2025

Leggi

Settembre 15, 2025 Alice Lione

FDA: Continuous Glucose Monitor Apps Correction: Dexcom, Inc. issues correction for G7 Apps and ONE+ Apps due to a software design error that does not alert users of unexpected sensor failure

12 settembre 2025

Leggi

Settembre 15, 2025 Alice Lione

Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council

Giorgino F, Alzaid F, Pantea Stoian A, et al.
Diabetologia. Pub. online 10 Sep 2025.

Leggi

Settembre 11, 2025 Alice Lione

Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: a randomized controlled trial

Thammakosol K, Jantarapootirat M, Traiwanatham S, Sriphrapradang C
Diabetes Obes Metab. Pub. online 3 Sep 2025.

Leggi

Settembre 11, 2025 Alice Lione

Mobile app-based intervention and cardiovascular risk factors in patients with uncontrolled type 2 diabetes: a randomized clinical trial

Zhang PZ, Guo D, Liu CQ, et al.
JAMA Netw Open. Pub. online 2 Sep 2025.

Leggi

Settembre 11, 2025 Alice Lione

Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis

de Visser HS, Waraich S, Chhabra M, et al.
JAMA Pediatr. Pub. online 8 Sep 2025.

Leggi

Settembre 11, 2025 Alice Lione

Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity: the HISTORI randomized clinical trial

Ganeshalingam AA, Uhrenholt N, Arnfred S, et al.
JAMA Psychiatry. Pub. online 3 Sep 2025.

Leggi

Settembre 11, 2025 Alice Lione

Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists: a systematic review and meta-analysis

Kalayci A, Januzzi JL, Mitsunami M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 31 Aug 2025.

Leggi

Settembre 7, 2025 Alice Lione

FDA launches green list to protect americans from illegal imported GLP-1 drug ingredients

5 settembre 2025

Leggi